Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

Study describing the efficacy and safety of regorafenib as maintenance therapy after first-line treatment in patients with bone sarcomas Recruiting

2024-514637-37-00 Patients with bone sarcomas other than chordoma, who ha 5 2020-02-11
A PROSPECTIVE, OPEN-LABEL, MULTICENTRE PHASE-II-TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF ZANUBRUTINIB (BGB-3111), A BTK INHIBI-TOR, PLUS… Recruiting

2023-504653-12-00 Patients with previously untreated Richter Transformati 4 2020-02-10
International study for children and adolescents with standard risk ALK-positive anaplastic large cell lymphoma (ALCL) estimating the effica… Recruiting

2022-501454-11-00 standard risk ALK-positive anaplastic large cell lympho 5 2020-02-05
Phase II randomized trial comparing atezolizumab versus atezolizumab plus bevacizumab as first-line treatment in PD-L1 high advanced non-sm… Recruiting

2024-517200-10-00 Advanced non-small-cell lung cancer 4 2020-01-31
A Phase 1/2, Open-Label, Multi-Center, First-in-Human Study of the Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of TPX-00… Recruiting

2024-512606-25-00 Advanced Solid Tumors 7 2019-12-20
Intra-operative evaluation of a novel FLUorescENt C-nnEt tracer in penile and tongue cancer Recruiting

2024-518046-25-00 penile carcinoma 4 2019-12-17
A phase II study on adjuvant vaccination with dendritic cells loaded with autologous tumor homogenate in resected stage IV rare cancers: neu… Recruiting

2023-510251-31-00 neuroendocrine tumors 4 2019-12-12
A phase I/II trial of TG4050, an individualised gene therapy, in patients with advanced cancer of the head and neck. Recruiting

2023-508561-33-00 Newly diagnosed, stage III or IV amenable to surgery, H 7 2019-12-12
Randomized Controlled Trial comparing two groups of Patients with High-Risk, Localized Soft Tissue Sarcoma of the Extremity: the first one r… Recruiting

2024-517858-10-00 high-risk soft tissue sarcoma of the extremity (undiffe 4 2019-12-11
SIOP RANDOMET 2017 Recruiting

2023-508926-91-00 Stage IV childhood renal tumour with pulmonary +/- non- 5 2019-12-05
Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or… Recruiting

2023-507149-27-00 Chemotherapy-induced Thrombocytopenia in Adult subjects 5 2019-11-04
Trial aimed at examinate the functionality and effectiveness of the drug "IO" in adult patients with a rare form of cancer that affect the c… Recruiting

2023-510516-39-00 Acute B-cell Lymphoblastic Leukemia with minimal residu 4 2019-10-30
Palbociclib plus fulvestrant in women with hormone receptor positive and human epidermal growth factor receptor type 2 negative locally adva… Recruiting

2024-513372-18-00 Pre- and post-menopausal women with HR+/HER2- LABC or M 4 2019-10-18
SGM-LARRC: Multicenter, open-label, controlled, parallel arms clinical study on the performance of SGM-101, a fluorochrome-labeled anti-carc… Recruiting

2024-510768-21-00 Rectal cancer 4 2019-10-16
A global study to assess the efficacy and safety of durvalumab in combination with bevacizumab or durvalumab alone in patients with hepatoce… Recruiting

2023-507689-26-00 Histologically or cytologically confirmed Locoregional 5 2019-10-07
Combination of ALpelisib and Trametinib in progressive REfractory Meningiomas Recruiting

2024-515836-61-00 Menangiomas 1 2019-09-30
Neoadjuvant treatment in rectal cancer with radiotherapy followed by atezolizumab and bevacizumab Recruiting

2024-517119-59-00 Rectal cancer 4 2019-09-26
Cabozantinib plus Durvalumab in patients with advanced and chemotherapy-treated bladder carcinoma, of urothelial and non-urothelial histolog… Recruiting

2023-509821-29-00 bladder carcinoma of urothelial and non-urothelial hist 4 2019-09-25
Clinical utility of a next generation sequencing-based “oncochip” for therapeutic decision in metastatic breast cancer. Study SHARP Recruiting

2024-513934-40-00 Metastatic breast cancer 4 2019-09-20
Glioblastoma treatment with irradiation and olaptesed pegol (NOX-A12) in unmethylated patients Recruiting

2024-510964-21-00 Glioblastoma 9 2019-09-12
Pre-operative phase II trial for breast cancer with nivolumab in combination with novel IO (BELLINI trial) Recruiting

2024-515080-54-00 Breast cancer 4 2019-08-15
Mevrometostat Treatment Of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma Recruiting

2023-509179-18-00 Castration Resistant Prostate Cancer (CRPC) 1 2019-08-13
Impact of atorvastatin on prostate cancer progression after initiation of androgen deprivation therapy Recruiting

2024-517854-91-00 Metastatic or high-risk recurrent prostate cancer manag 5 2019-08-05
LBL 2018 - International cooperative treatment protocol for children and adolescents with lymphoblastic lymphoma Recruiting

2023-508101-24-00 Lymphoblastic lymphoma 5 2019-08-01